Inventor · disambiguated record
Xianping Lu
Also filed as: LU XIANPING
9 granted patents·14 pending applications·28 citations·filing 2012–2024
81Inventor score
Files withSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD19SHENZHEN CHIPSCREEN BIOSCIENCES LTD2AKESO PHARMACEUTICALS INC1CHENGDU CHIPSCREEN PHARMACEUTICAL LTD1
Top patents by PatentIndex Score
23 records- 0188US10654815B2Urea compound and preparation method and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted May 19, 2020·15 cites·25 claims
- 0281US9573901B2Crystal form of chidamide, preparation method and use thereofSHENZHEN CHIPSCREEN BIOSCIENCES LTD·Filed 2012·Granted Feb 21, 2017·8 cites·3 claims
- 0380US10011571B2Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compoundSHENZHEN CHIPSCREEN BIOSCIENCES LTD·Filed 2015·Granted Jul 3, 2018·4 cites·21 claims
- 0473US10640465B2Method for preparing phenylalanine compoundSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted May 5, 2020·1 cites·10 claims
- 0562US2025188164A1Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranibAKESO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0660US11866452B2Biphenyl compound as immunomodulator, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Granted Jan 9, 2024·0 cites·2 claims
- 0754US11981638B2Phenyl amino sodium propionate derivative, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Granted May 14, 2024·0 cites·9 claims
- 0853US2024101548A1Hydroxamate compound, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 0952US2022000848A1Application of chidamideSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1051US2023117545A1Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1151US2023321074A1Use of chiauranib in combination with immune checkpoint inhibitor in antitumor therapySHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1250US2024382480A1Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1348US10882825B2Non-solvated crystal, preparation method and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted Jan 5, 2021·0 cites·16 claims
- 1448US2021315881A1Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1547US2021386705A1Application of chiglitazar and related compounds thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1645US12194054B2Application of Chidamide in combination with R-CHOP, and drug combinationSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Granted Jan 14, 2025·0 cites·4 claims
- 1745US2022401425A1Chidamide pharmaceutical composition, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1844US2022184056A1Use of kdm5a gene and atrx geneSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1942US2022184055A1Chiauranib for treatment of small cell lung cancerSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2040US2021139454A1Formamide compound, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 2139US10604529B2Fused imidazole compound having indoleamine 2,3-dioxygenase inhibitory activitySHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted Mar 31, 2020·0 cites·19 claims
- 2238US2023190705A1Drug combination for treating diabetes mellitus and complications thereof and pharmaceutical composition of drug combinationCHENGDU CHIPSCREEN PHARMACEUTICAL LTD·Filed 2021·Application pending·0 cites
- 2332US2020031771A1Substituted phenylpropionic acid enantiomer and manufacturing method, composition, and application of sameSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xianping Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →